- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股处于空头行情中，可能有短期反弹。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有53家主力机构披露2025-06-30报告期持股数据，持仓量总计4326.76万股，占流通A股4.71%
- 波段诊断：
-
技术面诊股
诊断结果：5.1技术面打败了13%的股票
技术面评分前10的股票
近期的平均成本为58.63元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为58.63元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"58.63","date":1767861210,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2026.01.09","stock":"-4.41","trade":"1.86","ind":"1.15"},{"date":"2026.01.08","stock":"-3.20","trade":"1.15","ind":"-0.51"},{"date":"2026.01.07","stock":"3.61","trade":"0.44","ind":"0.06"},{"date":"2026.01.06","stock":"0.07","trade":"0.51","ind":"1.40"},{"date":"2026.01.05","stock":"-1.00","trade":"3.09","ind":"2.24"},{"date":"2025.12.31","stock":"0.68","trade":"-0.07","ind":"-0.58"},{"date":"2025.12.30","stock":"-0.19","trade":"-0.48","ind":"0.49"},{"date":"2025.12.29","stock":"-2.39","trade":"-1.13","ind":"-0.49"},{"date":"2025.12.26","stock":"-1.43","trade":"-0.41","ind":"0.54"},{"date":"2025.12.25","stock":"1.26","trade":"0.35","ind":"0.33"},{"date":"2025.12.24","stock":"0.03","trade":"0.28","ind":"0.88"},{"date":"2025.12.23","stock":"-1.31","trade":"-0.30","ind":"0.27"},{"date":"2025.12.22","stock":"1.53","trade":"0.14","ind":"1.47"},{"date":"2025.12.19","stock":"1.90","trade":"1.80","ind":"0.66"},{"date":"2025.12.18","stock":"-2.82","trade":"0.51","ind":"-1.29"},{"date":"2025.12.17","stock":"3.06","trade":"0.69","ind":"2.40"},{"date":"2025.12.16","stock":"-8.43","trade":"-2.00","ind":"-1.51"},{"date":"2025.12.15","stock":"-0.75","trade":"-1.10","ind":"-1.10"},{"date":"2025.12.12","stock":"-0.15","trade":"-0.50","ind":"0.84"},{"date":"2025.12.11","stock":"1.99","trade":"-0.87","ind":"-1.27"},{"date":"2025.12.10","stock":"4.02","trade":"-0.07","ind":"0.29"}]
常山药业,深证成指,化学制药指数
压力支撑
该股压力位为58.02元，支撑位为55.16元。
[{"text":"\u538b\u529b\u4f4d","value":"58.02","date":1767888000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"55.16","date":1767888000,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.5资金面打败了9%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：01月09日 20:35
| 机构今日流向(万元) | 1109.44 | 机构5日流向(万元) | 4417.56 |
| 机构10日流向(万元) | -581.51 | 机构20日流向(万元) | -3826.93 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1013.03万股，其中基金净减仓10家，主力净增仓28家，暂未发现中长期投资价值。
截止2025-06-30，共53家主力机构（基金50家，一般法人3家），持仓量总计4326.76万股，占流通A股4.71%
其中，基金持仓与2024-12-31相比：
增仓：2家 ，增持 4.90万股
减仓：12家 ，减持 24.43万股
新出现在主力名单中：35家 ，持有133.22万股
从主力名单中消失：7家 ，原持有13.81万股
其中，基金持仓与2024-12-31相比：
增仓：2家 ，增持 4.90万股
减仓：12家 ，减持 24.43万股
新出现在主力名单中：35家 ，持有133.22万股
从主力名单中消失：7家 ，原持有13.81万股
消息面诊股
诊断结果：5.5消息面打败了34%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 创新药2025年“创双高”，A股公司出力，翻倍股涌
2026-01-07 - 常山药业：CSCJC3456片临床试验仍在进行中
2026-01-05 - 常山药业：股东协议转让的当事人是股东，而不是公司
2026-01-05 - 常山药业：艾本那肽上市审评进展请以后续公示信息为准
2026-01-05 - 常山药业：拟吸收合并全资子公司梅山科技
2025-12-30 - 常山药业：12月29日获融资买入7922.24万元
2025-12-30 - 行业周报|化学制药指数涨0.05%, 跑输上证指数
2025-12-26 - 常山药业（截止2025年12月19日）股东人数为3
2025-12-22 - 常山药业：公司暂未收到股东协议转让股份事项进展通知
2025-12-22 - 常山药业：创新药上市审评是否经历发补程序与最终审评
2025-12-22
消息列表
| 一般消息 | 高管变动 | 个人原因 | 2025-12-12 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-01 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-11-22 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-15 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-10 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-27 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-29 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.0行业面打败了85%的股票
化学制药行业最新资金流向
近10日来该行业走势明显向上，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，接近大盘。
[{"date":"2026.01.09","price":"1.15","value":"1.86"},{"date":"2026.01.08","price":"-0.51","value":"1.15"},{"date":"2026.01.07","price":"0.06","value":"0.44"},{"date":"2026.01.06","price":"1.40","value":"0.51"},{"date":"2026.01.05","price":"2.24","value":"3.09"},{"date":"2025.12.31","price":"-0.58","value":"-0.07"},{"date":"2025.12.30","price":"0.49","value":"-0.48"},{"date":"2025.12.29","price":"-0.49","value":"-1.13"},{"date":"2025.12.26","price":"0.54","value":"-0.41"},{"date":"2025.12.25","price":"0.33","value":"0.35"},{"date":"2025.12.24","price":"0.88","value":"0.28"},{"date":"2025.12.23","price":"0.27","value":"-0.30"},{"date":"2025.12.22","price":"1.47","value":"0.14"},{"date":"2025.12.19","price":"0.66","value":"1.80"},{"date":"2025.12.18","price":"-1.29","value":"0.51"},{"date":"2025.12.17","price":"2.40","value":"0.69"},{"date":"2025.12.16","price":"-1.51","value":"-2.00"},{"date":"2025.12.15","price":"-1.10","value":"-1.10"},{"date":"2025.12.12","price":"0.84","value":"-0.50"},{"date":"2025.12.11","price":"-1.27","value":"-0.87"},{"date":"2025.12.10","price":"0.29","value":"-0.07"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 前沿生物 | 48.94% | 55.96% | 5.8分 |
| 2 | 奥锐特 | 38.68% | 22.51% | 6.9分 |
| 3 | 上海谊众 | 32.93% | 29.45% | 6.5分 |
| 4 | 悦康药业 | 30.93% | 40.60% | 6.4分 |
| 5 | 宏源药业 | 27.23% | -11.60% | 5.1分 |
| 6 | 键凯科技 | 22.53% | 22.87% | 5.8分 |
| 8 | 福元医药 | 21.91% | 26.12% | 6.7分 |
| 10 | 海翔药业 | 18.48% | 15.06% | 6.1分 |
| 12 | 汇宇制药 | 16.59% | 23.66% | 6.6分 |
| 14 | 花园生物 | 14.80% | 8.73% | 5.7分 |
| 16 | 北陆药业 | 14.11% | 16.12% | 6.5分 |
| 18 | 百济神州 | 13.07% | 16.53% | 6.3分 |
| 20 | 奥赛康 | 10.97% | 16.47% | 6.8分 |
| 22 | 广济药业 | 10.12% | 20.77% | 6.1分 |
| 24 | 莱美药业 | 9.75% | 2.92% | 5.3分 |
| 26 | 国邦医药 | 8.99% | 3.10% | 6.3分 |
| 28 | 艾力斯 | 8.49% | 3.26% | 6.5分 |
| 30 | 富祥药业 | 8.12% | 7.54% | 5.7分 |
| 32 | 盟科药业 | 7.51% | 11.42% | 6.1分 |
| 34 | 科源制药 | 7.16% | 0.14% | 4.7分 |
| 36 | 圣诺生物 | 7.05% | 17.39% | 6.5分 |
| 38 | 博瑞医药 | 6.56% | 11.29% | 6.0分 |
| 40 | 民生健康 | 6.43% | 5.66% | 5.2分 |
| 42 | - | 6.33% | 6.04% | 分 |
| 44 | 吉贝尔 | 5.68% | 3.55% | 5.7分 |
| 46 | 复旦张江 | 5.62% | 6.51% | 5.5分 |
| 48 | 兴齐眼药 | 5.44% | 7.30% | 6.6分 |
| 50 | - | 5.20% | 4.27% | 分 |
| 52 | - | 5.05% | 6.88% | 分 |
| 54 | 富士莱 | 4.72% | 4.40% | 5.2分 |
| 56 | 贝达药业 | 4.61% | 8.91% | 6.2分 |
| 58 | - | 4.47% | 4.56% | 分 |
| 60 | 亿帆医药 | 4.21% | 7.69% | 6.2分 |
| 62 | 科伦药业 | 4.09% | 15.30% | 5.6分 |
| 64 | 天宇股份 | 3.62% | 7.84% | 6.3分 |
| 66 | 海欣股份 | 3.61% | 9.37% | 4.9分 |
| 68 | 亚太药业 | 3.32% | 6.57% | 5.9分 |
| 70 | 华邦健康 | 3.16% | 2.30% | 5.4分 |
| 72 | 海普瑞 | 3.01% | 4.41% | 6.0分 |
| 74 | 千红制药 | 2.97% | 5.73% | 5.8分 |
| 76 | 共同药业 | 2.81% | 5.99% | 5.1分 |
| 78 | - | 2.47% | 4.59% | 分 |
| 80 | 卫信康 | 2.28% | 6.75% | 5.8分 |
| 82 | ST诺泰 | 2.24% | 3.10% | 5.0分 |
| 84 | 海森药业 | 2.07% | 3.51% | 5.1分 |
| 86 | 德展健康 | 1.79% | 3.91% | 5.0分 |
| 88 | 新天地 | 1.73% | 4.50% | 5.6分 |
| 90 | 永安药业 | 1.60% | 6.10% | 5.5分 |
| 92 | 双鹭药业 | 1.55% | 6.51% | 6.0分 |
| 94 | 威尔药业 | 1.21% | 2.84% | 5.9分 |
| 96 | 海创药业 | 1.08% | 10.21% | 5.6分 |
| 98 | 誉衡药业 | 0.63% | 4.23% | 6.2分 |
| 100 | 东诚药业 | 0.55% | 5.53% | 5.5分 |
| 102 | 华润双鹤 | 0.48% | 1.97% | 5.7分 |
| 104 | 华北制药 | 0.18% | 2.53% | 5.4分 |
| 106 | 山河药辅 | -0.22% | 2.62% | 4.4分 |
| 108 | 九典制药 | -0.44% | 5.27% | 5.4分 |
| 110 | 汉商集团 | -0.84% | 3.39% | 5.6分 |
| 112 | 东北制药 | -1.47% | 2.87% | 6.0分 |
| 114 | ST天圣 | -1.60% | 1.03% | 4.7分 |
| 116 | 鲁抗医药 | -1.78% | 3.76% | 6.1分 |
| 118 | 莎普爱思 | -2.16% | 4.48% | 4.7分 |
| 120 | 新华制药 | -2.66% | 4.41% | 5.5分 |
| 122 | 亨迪药业 | -2.86% | 5.65% | 5.1分 |
| 124 | 健康元 | -3.08% | 3.64% | 5.7分 |
| 126 | 同和药业 | -3.50% | 2.93% | 4.5分 |
| 128 | 金石亚药 | -3.92% | 4.86% | 4.8分 |
| 130 | 润都股份 | -4.01% | 4.53% | 5.1分 |
| 132 | 北大医药 | -4.10% | 7.20% | 5.5分 |
| 134 | 赛分科技 | -4.27% | 3.72% | 5.4分 |
| 136 | 金城医药 | -4.80% | 6.36% | 5.0分 |
| 138 | 神奇制药 | -5.86% | 3.29% | 5.4分 |
| 140 | 百利天恒 | -6.04% | 6.44% | 5.5分 |
| 142 | 信立泰 | -7.48% | 10.31% | 6.0分 |
| 144 | 泽璟制药 | -7.69% | 6.58% | 5.6分 |
| 146 | 河化股份 | -9.82% | 1.80% | 5.8分 |
| 148 | 常山药业 | -11.96% | -5.02% | 4.7分 |
| 150 | 一品红 | -22.63% | 11.36% | 6.0分 |
| 152 | 必贝特 | - | 68.78% | 6.1分 |
| 154 | 辰欣药业 | - | 8.72% | 5.4分 |
| 156 | 能特科技 | - | 3.60% | 6.3分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 120/217 ， 141/217。
[{"date":"2025-09-30","value":"-2.91","vol":"1.51"},{"date":"2025-06-30","value":"-1.88","vol":"1.23"},{"date":"2025-03-31","value":"0.24","vol":"-0.14"},{"date":"2024-12-31","value":"-14.79","vol":"19.62"},{"date":"2024-09-30","value":"0.40","vol":"4.62"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-2.91 | -1.88 | 0.24 | -14.79 | 0.40 |
| 行业(%) | 1.51 | 1.23 | -0.14 | 19.62 | 4.62 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"15.91","vol":"49.36"},{"date":"2025-06-30","value":"14.54","vol":"49.33"},{"date":"2025-03-31","value":"23.10","vol":"49.14"},{"date":"2024-12-31","value":"16.10","vol":"50.78"},{"date":"2024-09-30","value":"18.06","vol":"50.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
15.91 | 14.54 | 23.10 | 16.10 | 18.06 |
| 行业(%) | 49.36 | 49.33 | 49.14 | 50.78 | 50.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 117/217 ， 144/217。
[{"date":"2025-09-30","value":"-13.11","vol":"142.98"},{"date":"2025-06-30","value":"-13.42","vol":"79.25"},{"date":"2025-03-31","value":"-12.10","vol":"-0.67"},{"date":"2024-12-31","value":"-26.92","vol":"18.07"},{"date":"2024-09-30","value":"-31.20","vol":"45.94"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-13.11 | -13.42 | -12.10 | -26.92 | -31.20 |
| 行业(%) | 142.98 | 79.25 | -0.67 | 18.07 | 45.94 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-714.77","vol":"-3.26"},{"date":"2025-06-30","value":"37.98","vol":"58.57"},{"date":"2025-03-31","value":"106.13","vol":"-11.22"},{"date":"2024-12-31","value":"79.88","vol":"-22.02"},{"date":"2024-09-30","value":"101.88","vol":"-34.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-714.77 | 37.98 | 106.13 | 79.88 | 101.88 |
| 行业(%) | -3.26 | 58.57 | -11.22 | -22.02 | -34.66 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 130/217 ， 142/217。
[{"date":"2025-09-30","value":"0.15","vol":"0.31"},{"date":"2025-06-30","value":"0.11","vol":"0.21"},{"date":"2025-03-31","value":"0.06","vol":"0.10"},{"date":"2024-12-31","value":"0.23","vol":"0.43"},{"date":"2024-09-30","value":"0.17","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.15 | 0.11 | 0.06 | 0.23 | 0.17 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.42","vol":"1.94"},{"date":"2025-06-30","value":"0.32","vol":"1.30"},{"date":"2025-03-31","value":"0.15","vol":"0.66"},{"date":"2024-12-31","value":"0.57","vol":"3.19"},{"date":"2024-09-30","value":"0.42","vol":"2.12"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.42 | 0.32 | 0.15 | 0.57 | 0.42 |
| 行业(次) | 1.94 | 1.30 | 0.66 | 3.19 | 2.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"-16.27","vol":"4.43"},{"date":"2025-06-30","value":"30.15","vol":"2.74"},{"date":"2025-03-31","value":"39.81","vol":"-26.98"},{"date":"2024-12-31","value":"-38.14","vol":"-373.99"},{"date":"2024-09-30","value":"-23.56","vol":"-9.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -16.27 | 30.15 | 39.81 | -38.14 | -23.56 |
| 行业 | 4.43 | 2.74 | -26.98 | -373.99 | -9.47 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.31","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.21","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.31 | - | 3.21 | - |
| 行业 | 0.00 | 1.73 | 0.00 | 2.00 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 87/217 ， 78/217。
[{"date":"2025-09-30","value":"0.87","vol":"3.50"},{"date":"2025-06-30","value":"0.79","vol":"3.69"},{"date":"2025-03-31","value":"0.82","vol":"3.61"},{"date":"2024-12-31","value":"0.91","vol":"3.36"},{"date":"2024-09-30","value":"1.13","vol":"3.67"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.87 | 0.79 | 0.82 | 0.91 | 1.13 |
| 行业 | 3.50 | 3.69 | 3.61 | 3.36 | 3.67 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.24","vol":"2.75"},{"date":"2025-06-30","value":"0.23","vol":"2.90"},{"date":"2025-03-31","value":"0.25","vol":"2.83"},{"date":"2024-12-31","value":"0.23","vol":"2.65"},{"date":"2024-09-30","value":"0.31","vol":"2.93"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.24 | 0.23 | 0.25 | 0.23 | 0.31 |
| 行业 | 2.75 | 2.90 | 2.83 | 2.65 | 2.93 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 64/217 ， 8/217。
[{"date":"2025-09-30","value":"68.26","vol":"33.63"},{"date":"2025-06-30","value":"66.97","vol":"33.66"},{"date":"2025-03-31","value":"66.14","vol":"33.90"},{"date":"2024-12-31","value":"66.04","vol":"34.07"},{"date":"2024-09-30","value":"62.19","vol":"32.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
68.26 | 66.97 | 66.14 | 66.04 | 62.19 |
| 行业(%) | 33.63 | 33.66 | 33.90 | 34.07 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.10","vol":"0.94"},{"date":"2025-06-30","value":"1.98","vol":"0.88"},{"date":"2025-03-31","value":"1.92","vol":"1.47"},{"date":"2024-12-31","value":"1.91","vol":"0.84"},{"date":"2024-09-30","value":"1.60","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
2.10 | 1.98 | 1.92 | 1.91 | 1.60 |
| 行业(%) | 0.94 | 0.88 | 1.47 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"2.34","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.18","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-12.40","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-2.49","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]